The OMNI Surgical System, an implant-free MIGS device from Sight Sciences, allows glaucoma surgeons to lower patients’ IOP by targeting all three points of resistance: the distal collector channel, Schlemm’s canal, and the trabecular meshwork. As a result, this single device is usable in two procedures: canaloplasty and trabeculotomy.
Join Steve Mitchley, Sight Sciences’ Head of Sales and Operations, UK, on the floor of ESCRS 2022 to see how this system helps lower glaucoma patients’ IOP while making surgery more efficient and easier for doctors.
